AVALO THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Due in Two Years
AVALO THERAPEUTICS, INC. (AVTX) had Operating Leases, Future Minimum Payments, Due in Two Years of $155.81 thousand as of 2018-09-30, per its 10-K filed 2019-03-18.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-03-18
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $155.81K; Operating Leases, Future Minimum Payments, Due in Two Years as first filed $138.09K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $0.00.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $158.72K.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $158.72K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years | Operating Leases, Future Minimum Payments, Due in Two Years as first filed |
|---|---|---|
| 2018-09-30 | $155.81K 10-K · filed 2019-03-18 | $138.09K 10-Q · filed 2018-11-13 |
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 | |
| 2017-09-30 | $158.72K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $158.72K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $158.72K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $158.72K 10-K · filed 2017-03-14 | |
| 2016-09-30 | $154.84K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $154.84K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $154.84K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $154.84K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |